Letter to editor regarding a review of MF59-adjuvanted influenza vaccine by Gartner et al

被引：1
|
作者：
Yin, J. Kevin [1 ,2 ]
Harris, Rebecca C. [3 ,4 ]
Loiacono, Matthew M. [5 ]
Chit, Ayman [6 ]
Samson, Sandrine I. [6 ,7 ]
机构：
[1] Sanofi, Global Med Affairs, Singapore, Singapore
[2] Univ Sydney, Sydney, NSW, Australia
[3] Sanofi, Global Med Evidence Generat, Singapore, Singapore
[4] London Sch Hyg & Trop Med, London, England
[5] Sanofi, Global Med Evidence Generat, Swiftwater, PA USA
[6] Sanofi, Global Med Affairs, Lyon, France
[7] Univ Toronto, Toronto, ON, Canada
来源：
VACCINE | 2023年 / 41卷 / 27期
关键词：
D O I：
10.1016/j.vaccine.2022.12.034
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3948 / 3948
页数：1
相关论文
共 50 条
  • [21] Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations
    Atmar, Robert L.
    Keitel, Wendy A.
    Patel, Shital M.
    Katz, Jacqueline M.
    She, Dewei
    El Sahly, Hana
    Pompey, Justine
    Cate, Thomas R.
    Couch, Robert B.
    CLINICAL INFECTIOUS DISEASES, 2006, 43 (09) : 1135 - 1142
  • [22] Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season
    Amicizia, Daniela
    Domnich, Alexander
    Lai, Piero Luigi
    Orsi, Andrea
    Icardi, Giancarlo
    Tkach-Motulyak, Oksana
    Panatto, Donatella
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [23] Increased immunogenicity with an MF59-adjuvanted influenza vaccine (FLUAD®) compared with a conventional subunit vaccine (Agrippal®) in renal transplant recipients
    Pollok, M
    Geiger, H
    Floege, J
    Paschke, R
    Abendroth, D
    Blenzle, U
    Ypma, E
    Banzhoff, A
    OPTIONS FOR THE CONTROL OF INFLUENZA V, 2004, 1263 : 453 - 456
  • [24] MF59-adjuvanted trivalent seasonal influenza vaccine compared to high-dose trivalent seasonal influenza vaccine among older adults, a systematic literature review
    Dang, J.
    McGovern, I.
    Haag, M.
    Coleman, B.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2023, 71 : S42 - S43
  • [25] Exposure to MF59-adjuvanted influenza vaccines during pregnancy-A retrospective analysis
    Tsai, Theodore
    Kyaw, Moe H.
    Novicki, Deborah
    Nacci, Pantaleo
    Rai, Saroj
    Clemens, Ralf
    VACCINE, 2010, 28 (07) : 1877 - 1880
  • [26] Immunogenicity and Safety of MF59-Adjuvanted Quadrivalent Influenza Vaccine Compared with a Nonadjuvanted, Quadrivalent Influenza Vaccine in Adults 50-64 Years of Age
    Poder, Airi
    Oberije, Janine
    Meyer, Jay
    Heymer, Peter
    Molrine, Deborah
    Versage, Eve
    Isakov, Leah
    Zhang, Qiuhong
    Hohenboken, Matthew
    VACCINES, 2023, 11 (10)
  • [27] Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age
    Puig-Barberà, J
    Diez-Domingo, J
    Hoyos, SP
    Varea, AB
    Vidal, DG
    VACCINE, 2004, 23 (03) : 283 - 289
  • [28] Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
    Vesikari, Timo
    Karvonen, Aino
    Tilman, Sandrine
    Borkowski, Astrid
    Montomoli, Emanuele
    Banzhoff, Angelika
    Clemens, Ralf
    PEDIATRICS, 2010, 126 (04) : E762 - E770
  • [29] Safety of MF59-adjuvanted A/H1N1 influenza vaccine in pregnancy: a comparative cohort study
    Heikkinen, Terho
    Young, James
    van Beek, Erik
    Franke, Henk
    Verstraeten, Thomas
    Weil, John G.
    Della Cioppa, Giovanni
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 207 (03)
  • [30] Effectiveness of the MF59-adjuvanted trivalent seasonal influenza vaccine among adults aged 65 or older; a systematic review and meta-analysis
    Kennedy, Alex
    Sanderson, Ruth
    McGovern, Ian
    Haag, Mendel
    AUSTRALASIAN JOURNAL ON AGEING, 2021, 40 : 67 - 68
12345